Most recently, a systematic review and meta-analysis confirmed elevated IL-6 serum levels in HCC patients compared to healthy controls, and showed that HCC patients had even higher IL-6 levels than patients with other chronic liver diseases like cirrhosis or hepatitis [79]. The gene discussed is IL6; the disease is hepatocellular carcinoma.